Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

Keith Speights, The Motley Fool
·4-min read
Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna
Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

Last week, Pfizer and its partner BioNTech announced great efficacy results for their COVID-19 vaccine candidate BNT162b2. While Pfizer and Moderna are the leaders now, that doesn't mean they'll maintain the position indefinitely.